Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Why Delcath Systems (NASDAQ:DCTH) Soared on the Russell 2000: Hepzato Sales Surged and It Raised Guidance

● The 2026Revenueforecast rose to $115 million to $117 million.

Nitish Kishor | 10 November 2026

Why DraftKings (NASDAQ:DKNG) Was in Focus on the Russell 1000: Three Analysts Downgraded the Stock

● JPMorgan flagged promotional competition as a concern.

Nitish Kishor | 10 November 2026

Why Dole plc (NYSE:DOLE) Was in Focus on the NYSE Composite: It Cut Its 2026 EBITDA Outlook

● Dole's update arrived as investors favored riskier stocks over defensive ones.

Nitish Kishor | 10 November 2026

Why Eupraxia Pharmaceuticals (NASDAQ:EPRX) Climbed on the Nasdaq Composite: RBC Initiated Coverage at Outperform

Key Highlights● Eupraxia climbed on November 9 after RBC initiated coverage.● The rating is Outperform with a $14 price target.● The shares rose to about $6.89.● An interim EP-104GI readout is expected in December.A bullish first lookEupraxia Pharmaceuticals (NASDAQ:EPRX) climbed on Monday, November 9, …

Nitish Kishor | 10 November 2026
Support

Hi! How can we help you today?

Loading…